angiotensin ii has been researched along with cinnarizine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
| Van Nueten, JM; Wellens, D | 1 |
| Lambelin, G; Reuse-Blom, S; Roba, J | 1 |
1 review(s) available for angiotensin ii and cinnarizine
| Article | Year |
|---|---|
Mechanisms of vasodilatation and antivasoconstriction.
Topics: Actins; Adrenergic alpha-Antagonists; Angiotensin II; Arterial Occlusive Diseases; Bradykinin; Calcium; Cinnarizine; Dose-Response Relationship, Drug; Humans; Muscle, Smooth; Myosins; p-Methoxy-N-methylphenethylamine; Papaverine; Piperazines; Prostaglandins; Theophylline; Vasoconstriction; Vasodilation | 1979 |
2 other study(ies) available for angiotensin ii and cinnarizine
| Article | Year |
|---|---|
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
In vivo antispasmodic activity of Sulcotidil.
Topics: Angiotensin II; Animals; Blood Pressure; Cats; Cerebrovascular Circulation; Cinnarizine; Dogs; Female; Hindlimb; Male; Microcirculation; Norepinephrine; Papaverine; Parasympatholytics; Propanolamines; Rabbits; Regional Blood Flow; Time Factors; Vinca Alkaloids | 1976 |